Mr. Andrew Morris reports

SQI DIAGNOSTICS TO EXTEND WARRANT EXPIRY

SQI Diagnostics Inc. has received approval from the TSX Venture Exchange to extend the expiry of 5,126,044 outstanding common share purchase warrants of the company, which were issued in connection with the company's May, 2013, private placement financing.

Each warrant entitles the holder thereof to purchase one common share of the company at any time until the close of business on May 1, 2015, at an exercise price of $1.10 per common share. The warrants will be amended, effective May 1, 2015, to extend the term of such warrants until May 1, 2018. In addition, at any time prior to the expiry date, as amended, should the 20-day trailing average price exceed $1.43, warrantholders shall have 30 days to exercise this series of warrants and any unexercised warrants shall expire thereafter. All other provisions of the warrants will remain the same.

We seek Safe Harbor.